Figure 9From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitroPathomorphological effects of L-OHP and CIK on the model of gastric cancer. a) Effect of L-OHP (4.5 mg/kg, HE × 100) on the model of gastric cancer. b) Effect of CIK (4 × 107/0.2 mL, HE × 100) on the model of gastric cancer. c) Effect of L-OHP+CIK (HE × 100) on the model of gastric cancer. d) Effect of L-OHP (2.25 mg/kg, EM, × 10.0 K) on the model of gastric cancer. e) Effect of CIK (2 × 107/0.2 mL, EM, × 7.0 K) on the model of gastric cancer. f) Effect of L-OHP+CIK (EM, × 7.0 K) on the model of gastric cancer.Back to article page